Uncategorized
STAAR Surgical Reports Record Second Quarter Results for Total Revenue, ICL Sales and ICL Units
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended June 28, 2019. Second Quarter 2019 Overview Net Sales of $39.7 Million (Up 17%) as Reported and $40.3 Million (Up 19%) Constant Currency from the Prior Year Quarter ICL Sales of $34.4 Million (Up 26%) as Reported and $34.9 Million (Up 28%) Constan